⌘K

Login Start Free

Home/Filings/144/0002086827-25-000002

144//SEC Filing

Taysha Gene Therapies, Inc. 144

Accession 0002086827-25-000002

CIK 0002086827other

View on SEC.gov Company Profile

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 7:18 PM ET

Size

4.8 KB

Accession

0002086827-25-000002

Documents

1 file

144
primary_doc.xmlPrimary

Issuer

Haque-Ahmed Rumana

CIK 0002086827

Entity typeother

Related Parties

1

filerCIK 0002086827

Filing Metadata

Form type: 144
Filed: Sep 21, 8:00 PM ET
Accepted: Sep 22, 7:18 PM ET
Size: 4.8 KB

View on SEC.gov